Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/Hims & Hers stock drops 14% pre-market after weak Q1 but upbeat Q2 outlook.

HIMS

$37.10

-$0.07 -0.19%

Hims & Hers stock drops 14% pre-market after weak Q1 but upbeat Q2 outlook.

Company Fundamentals

12 May 2026

Seeking Alpha

View Source

Bearish

Hims & Hers shares fell about 14% in pre-market trading following a disappointing Q1 report, attributed to timing of the Novo Nordisk deal and tough year-over-year comparisons. Despite the initial drop, analysts see the Q2 guidance beat and raised full-year 2026 outlook as signs of improved profitability and revenue diversification. The stock's pullback is viewed as a buying opportunity, with confidence that Hims & Hers is positioned to exceed future expectations after resetting investor outlooks.

More News (HIMS)

Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent.

Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...

Market News

Bearish

10 hours ago